These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3921023)
1. Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex. Rode W; Jastreboff MM; Bertino JR Biochem Biophys Res Commun; 1985 Apr; 128(1):345-51. PubMed ID: 3921023 [TBL] [Abstract][Full Text] [Related]
2. Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. veer Reddy GP; Pardee AB Nature; 1983 Jul 7-13; 304(5921):86-8. PubMed ID: 6408486 [TBL] [Abstract][Full Text] [Related]
4. Coordinate inhibition of DNA synthesis and thymidylate synthase activity following DNA damage and repair. Boorstein RJ; Pardee AB Biochem Biophys Res Commun; 1983 Nov; 117(1):30-6. PubMed ID: 6419736 [TBL] [Abstract][Full Text] [Related]
5. Allosteric interaction of components of the replitase complex is responsible for enzyme cross-inhibition. Plucinski TM; Fager RS; Reddy GP Mol Pharmacol; 1990 Jul; 38(1):114-20. PubMed ID: 1695315 [TBL] [Abstract][Full Text] [Related]
6. A method for the synchronization of cultured cells with aphidicolin: application to the large-scale synchronization of L1210 cells and the study of the cell cycle regulation of thymidylate synthase and dihydrofolate reductase. Matherly LH; Schuetz JD; Westin E; Goldman ID Anal Biochem; 1989 Nov; 182(2):338-45. PubMed ID: 2514611 [TBL] [Abstract][Full Text] [Related]
7. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro. Yalowich JC; Kalman TI Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352 [TBL] [Abstract][Full Text] [Related]
8. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells. Balzarini J; De Clercq E Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920 [TBL] [Abstract][Full Text] [Related]
9. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells. Xu YZ; Plunkett W J Biol Chem; 1993 Oct; 268(30):22363-8. PubMed ID: 8226747 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma. FitzGerald GB; Wick MM J Invest Dermatol; 1987 Jan; 88(1):66-70. PubMed ID: 2947954 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of thymidylate synthase by hydroxyurea in rapidly proliferating P815 mastocytoma cells. Boehm TL; Kreis W; Drahovsky D Biochim Biophys Acta; 1982 Jan; 696(1):52-6. PubMed ID: 6805512 [TBL] [Abstract][Full Text] [Related]
13. Relations between synthesis of deoxyribonucleotides and DNA replication in 3T6 fibroblasts. Nicander B; Reichard P J Biol Chem; 1985 May; 260(9):5376-81. PubMed ID: 3921544 [TBL] [Abstract][Full Text] [Related]
14. Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes. Fitzgerald GB; Wick MM Biochem Pharmacol; 1986 Jan; 35(2):271-5. PubMed ID: 3510622 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine. FitzGerald GB; Ratliff J; Wick MM Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076 [TBL] [Abstract][Full Text] [Related]
16. Inhibition by aphidicolin and dideoxythymidine triphosphate of a multienzyme complex of DNA synthesis from human cells. Wickremasinghe RG; Hoffbrand AV FEBS Lett; 1983 Aug; 159(1-2):175-9. PubMed ID: 6409668 [TBL] [Abstract][Full Text] [Related]
17. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717. Jackman AL; Taylor GA; Calvert AH; Harrap KR Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375 [TBL] [Abstract][Full Text] [Related]
18. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics. Jackman AL; Calvert AH; Hart LI; Harrap KR Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434 [No Abstract] [Full Text] [Related]
20. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA. Balzarini J; De Clercq E; Ayusawa D; Seno T Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]